Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study.
This study was designed to assess unique baseline factors associated with subsequent hospitalizations in a cohort of outpatients with cirrhosis. A cohort of 193 patients with cirrhosis was recruited from an outpatient liver disease clinic at a single, tertiary medical center. Comorbidities, prescrip...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5693413?pdf=render |
id |
doaj-da629d6de75e43e2b54f7587ddb2e2b2 |
---|---|
record_format |
Article |
spelling |
doaj-da629d6de75e43e2b54f7587ddb2e2b22020-11-24T21:30:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011211e018717610.1371/journal.pone.0187176Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study.Shari S RogalViyan UdawattaImo AkpanAkshata MogheAlexis ChidiAmit ShettyEva SzigethyKlaus BielefeldtAndrea DiMartiniThis study was designed to assess unique baseline factors associated with subsequent hospitalizations in a cohort of outpatients with cirrhosis. A cohort of 193 patients with cirrhosis was recruited from an outpatient liver disease clinic at a single, tertiary medical center. Comorbidities, prescription medications, liver disease symptoms and severity, and psychiatric and pain symptoms were assessed at baseline using validated instruments. Inflammatory markers were measured using standardized Luminex assays. Subsequent hospitalizations and the primary admission diagnoses were collected via chart review. Multivariable models were used to evaluate which baseline factors were associated with time to hospitalization and number of hospitalizations. The cohort consisted of 193 outpatients, with an average age of 58±9 and model for end-stage liver disease (MELD) score of 12±5. Over follow-up, 57 (30%) were admitted to the hospital. The factors associated with time to hospitalization included the severity of liver disease (HR/MELD point:1.10, 95% CI:1.04,1.16), ascites (HR: 1.90, 95% CI: 1.01, 3.58), baseline symptoms of depression (HR:2.34, 95% CI:1.28,4.25), sleep medications (HR:1.81, 95% CI:1.01, 3.22) and IL-6 (HR:1.43, 95% CI: 1.10, 1.84). Similarly the number admissions was significantly associated with MELD (IIR: 1.08, CI: 1.07,1.09), ascites (IIR: 4.15, CI:3.89, 4.43), depressive symptoms (IIR:1.54, CI:1.44,1.64), IL-6 (IIR:1.26, CI:1.23,1.30), sleep medications (IIR:2.74, CI:2.57, 2.93), and widespread pain (IIR: 1.61, CI: 1.50, 1.73). In conclusion, consistent with prior studies, MELD and ascites were associated with subsequent hospitalization. However, this study also identified other factors associated with hospitalization including inflammation, depressive symptoms, sleep medication use, and pain.http://europepmc.org/articles/PMC5693413?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shari S Rogal Viyan Udawatta Imo Akpan Akshata Moghe Alexis Chidi Amit Shetty Eva Szigethy Klaus Bielefeldt Andrea DiMartini |
spellingShingle |
Shari S Rogal Viyan Udawatta Imo Akpan Akshata Moghe Alexis Chidi Amit Shetty Eva Szigethy Klaus Bielefeldt Andrea DiMartini Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study. PLoS ONE |
author_facet |
Shari S Rogal Viyan Udawatta Imo Akpan Akshata Moghe Alexis Chidi Amit Shetty Eva Szigethy Klaus Bielefeldt Andrea DiMartini |
author_sort |
Shari S Rogal |
title |
Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study. |
title_short |
Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study. |
title_full |
Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study. |
title_fullStr |
Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study. |
title_full_unstemmed |
Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study. |
title_sort |
risk factors for hospitalizations among patients with cirrhosis: a prospective cohort study. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
This study was designed to assess unique baseline factors associated with subsequent hospitalizations in a cohort of outpatients with cirrhosis. A cohort of 193 patients with cirrhosis was recruited from an outpatient liver disease clinic at a single, tertiary medical center. Comorbidities, prescription medications, liver disease symptoms and severity, and psychiatric and pain symptoms were assessed at baseline using validated instruments. Inflammatory markers were measured using standardized Luminex assays. Subsequent hospitalizations and the primary admission diagnoses were collected via chart review. Multivariable models were used to evaluate which baseline factors were associated with time to hospitalization and number of hospitalizations. The cohort consisted of 193 outpatients, with an average age of 58±9 and model for end-stage liver disease (MELD) score of 12±5. Over follow-up, 57 (30%) were admitted to the hospital. The factors associated with time to hospitalization included the severity of liver disease (HR/MELD point:1.10, 95% CI:1.04,1.16), ascites (HR: 1.90, 95% CI: 1.01, 3.58), baseline symptoms of depression (HR:2.34, 95% CI:1.28,4.25), sleep medications (HR:1.81, 95% CI:1.01, 3.22) and IL-6 (HR:1.43, 95% CI: 1.10, 1.84). Similarly the number admissions was significantly associated with MELD (IIR: 1.08, CI: 1.07,1.09), ascites (IIR: 4.15, CI:3.89, 4.43), depressive symptoms (IIR:1.54, CI:1.44,1.64), IL-6 (IIR:1.26, CI:1.23,1.30), sleep medications (IIR:2.74, CI:2.57, 2.93), and widespread pain (IIR: 1.61, CI: 1.50, 1.73). In conclusion, consistent with prior studies, MELD and ascites were associated with subsequent hospitalization. However, this study also identified other factors associated with hospitalization including inflammation, depressive symptoms, sleep medication use, and pain. |
url |
http://europepmc.org/articles/PMC5693413?pdf=render |
work_keys_str_mv |
AT sharisrogal riskfactorsforhospitalizationsamongpatientswithcirrhosisaprospectivecohortstudy AT viyanudawatta riskfactorsforhospitalizationsamongpatientswithcirrhosisaprospectivecohortstudy AT imoakpan riskfactorsforhospitalizationsamongpatientswithcirrhosisaprospectivecohortstudy AT akshatamoghe riskfactorsforhospitalizationsamongpatientswithcirrhosisaprospectivecohortstudy AT alexischidi riskfactorsforhospitalizationsamongpatientswithcirrhosisaprospectivecohortstudy AT amitshetty riskfactorsforhospitalizationsamongpatientswithcirrhosisaprospectivecohortstudy AT evaszigethy riskfactorsforhospitalizationsamongpatientswithcirrhosisaprospectivecohortstudy AT klausbielefeldt riskfactorsforhospitalizationsamongpatientswithcirrhosisaprospectivecohortstudy AT andreadimartini riskfactorsforhospitalizationsamongpatientswithcirrhosisaprospectivecohortstudy |
_version_ |
1725964395698192384 |